Drug Trial Radar · NCT03495024
Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Last checked: Nov 20, 2026Latest source record: Mar 22, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
10
Planned (sponsor's estimate)
Start
Jan 1, 2019
Primary completion
Apr 30, 2020
Study completion Jun 30, 2020
Sponsor
- Lead sponsor
- Corporal Michael J. Crescenz VA Medical CenterFederal agency
- Sponsor type
- Federal agency
- First posted
- Apr 11, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To test the feasibility of studying effects of smoking cessation with varenicline on antipsychotic drug-induced neurological side effects, we propose a 12 week pilot study of smoking cessation treatment with varenicline in 10 schizophrenia or schizoaffective disorder patients who are actively smoking and have pre-existing TD while receiving stable doses of antipsychotics. Subjects will be followed after a 2 week baseline period to assess changes in smoking status and neurological symptoms using standardized rating scales. The aim is to examine clinically significant effects on antipsychotic-induced neurological side effects that may warrant further investigation.
Conditions
- Schizophrenia
- Schizoaffective Disorder
- Tobacco Smoking
- Tardive Dyskinesia
- Parkinsonism
Interventions
VareniclineDrug
Oral medication approved to facilitate smoking cessation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Self-reported 7-day point prevalence of abstinence prior to week 12Time frame: 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Corporal Michael J Crescenz VA Medical Center
Philadelphia, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.